Appropriate models are crucial to the study of early lung development, the pathobiology of developmental processes and investigation of the factors regulating the developmental events. The ability to manipulate suspected regulatory components of development is essential to productive studies. The primary explant culture model of fetal lung has been well characterized and mimics many maturational events characteristic of fetal lung in vivo. The Tissue Culture Core Laboratory has extensive experience in primary culture of lung tissue and cells, utilizing both explant culture and the recently developed and characterized monolayer culture of differentiated alveolar epithelial cells. The latter model of type II cell differentiation in vitro has been extensively characterized and provides an easily manipulated model of differentiation. These cells, as well as fibroblasts and pulmonary cell lines are useful for transfection, transduction and other approaches to study altered gene expression. This system of epithelial cell differentiation in vitro will be extended to the fetal rat and mouse lung as required for proposed studies with rodent lung; the mouse model has obvious advantages, particularly the availability of numerous genetic variants. The lung bud organ culture model provides an early model of mesenchymal, epithelial and vascular cell development, as well as cell type interaction during branching and epithelial cell maturation.
The specific aims of this Core are to support the research goals of Projects I-V as follows: 1. Provide cultured tissue for all Projects: a) Prepare and maintain primary explant cultures of fetal lung as requested (human, rat, mouse); b) Prepare enriched isolated cell populations (type II cells, both undifferentiated and differentiated; fibroblasts) from fetal human, rat, mouse lung for short term study; c) Prepare mouse lung bud cultures as needed; d) Provide monolayer cultures of pulmonary and other cell lines when requested. 2. To maintain a bank of necropsy lung samples of interest (sectioned slides, frozen tissue, etc.), including those from infants with BP-D, SP-B deficiency and normal donor lung from transplants and to provide them to all Projects upon request. The Core will also assist distribution of sheep and rat tissues and slides as needed. 3. Co-ordinate and organize integrated use of culture setups between Projects, to maximize efficient use of tissue resources and facilitate data correlation and exchange. 4. Fix and embed tissue samples for microscopy (light, electron) as needed. 5. Provide training for fellows and technical staff in primary culture models, both manipulation technical issues as well as scientific expertise in experimental application of the models to solve problems. 6. Provide an interactive focal center for exchange of ideas, and integration of hypotheses and experimental findings by various SCOR investigators.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Specialized Center (P50)
Project #
5P50HL056401-07
Application #
6655314
Study Section
Project Start
2002-08-01
Project End
2003-07-31
Budget Start
1997-10-01
Budget End
1998-09-30
Support Year
7
Fiscal Year
2002
Total Cost
$243,516
Indirect Cost
Name
Children's Hospital of Philadelphia
Department
Type
DUNS #
073757627
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Hamvas, Aaron; Deterding, Robin; Balch, William E et al. (2014) Diffuse lung disease in children: summary of a scientific conference. Pediatr Pulmonol 49:400-9
Merrill, J D; Ballard, P L; Courtney, S E et al. (2011) Pilot trial of late booster doses of surfactant for ventilated premature infants. J Perinatol 31:599-606
Hibbs, Anna Maria; Black, Dennis; Palermo, Lisa et al. (2010) Accounting for multiple births in neonatal and perinatal trials: systematic review and case study. J Pediatr 156:202-8
Walsh, Michele C; Hibbs, Anna Maria; Martin, Camilia R et al. (2010) Two-year neurodevelopmental outcomes of ventilated preterm infants treated with inhaled nitric oxide. J Pediatr 156:556-61.e1
Posencheg, M A; Gow, A J; Truog, W E et al. (2010) Inhaled nitric oxide in premature infants: effect on tracheal aspirate and plasma nitric oxide metabolites. J Perinatol 30:275-80
Albertine, Kurt H; Dahl, Mar Janna; Gonzales, Linda W et al. (2010) Chronic lung disease in preterm lambs: effect of daily vitamin A treatment on alveolarization. Am J Physiol Lung Cell Mol Physiol 299:L59-72
Zupancic, John A F; Hibbs, Anna Maria; Palermo, Lisa et al. (2009) Economic evaluation of inhaled nitric oxide in preterm infants undergoing mechanical ventilation. Pediatrics 124:1325-32
Kolla, Venkatadri; Gonzales, Linda W; Bailey, Nicole A et al. (2009) Carcinoembryonic cell adhesion molecule 6 in human lung: regulated expression of a multifunctional type II cell protein. Am J Physiol Lung Cell Mol Physiol 296:L1019-30
Ballard, Philip L; Truog, William E; Merrill, Jeffrey D et al. (2008) Plasma biomarkers of oxidative stress: relationship to lung disease and inhaled nitric oxide therapy in premature infants. Pediatrics 121:555-61
Davis, Christiana W; Gonzales, Linda W; Ballard, Roberta A et al. (2008) Expression of nitric oxide synthases and endogenous NO metabolism in bronchopulmonary dysplasia. Pediatr Pulmonol 43:703-9

Showing the most recent 10 out of 94 publications